Last reviewed · How we verify

NCT06737185

Comparison of Speech Understanding Between Tonotopy-based Fitting and Setting Based on Evolutionary Algorithms

Recruiting now NA Last updated 4 March 2025
What this trial tests

NA trial testing EAFS4T: modification with evolutionary algorithm of tonotopic-based fitting in Sensorineural Hearing Loss, Bilateral in 22 participants. Currently enrolling.

Timeline
15 January 2025
Primary endpoint
15 January 2027
15 January 2028

Quick facts

Lead sponsorMED-EL Elektromedizinische Geräte GesmbH
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment22
Start date15 January 2025
Primary completion15 January 2027
Estimated completion15 January 2028
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

MED-EL Elektromedizinische Geräte GesmbH — full company profile →

Who can join

18 and older, any sex, with Sensorineural Hearing Loss, Bilateral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Main objective: Compare speech recognition in noise with tonotopic setting (FS4T) and with tonotopic fitting modified by evolutionary algorithm (EAFS4T) in adult patients implanted for 6 months or more with a MED-EL cochlear implant with FS4T. Secondary objectives: Comparison of FS4T and EAFS4T settings * for speech recognition in quiet * for subjective auditory spatial perception * for subjective auditory and musical perception

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sensorineural Hearing Loss, Bilateral

Currently open trials in the same condition.

Other MED-EL Elektromedizinische Geräte GesmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06737185.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing